CA 125 Modifications Throughout Menstrual Cycle and following GnRH-Analog Administration to Diagnose Endometriosis as Cause of Chronic Pelvic Pain. A Prospective Controlled Study

Roberta Venturella, Pietro D’Alessandro, Francesco Gallo, Michele Morelli, Fulvio Zullo
In: Journal of Endometriosis · 2011 · vol. 3(3) , pp. 151–158 · doi:10.5301/je.2011.8911 · W1631089422
article OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Serum CA 125 levels are significantly higher in the early follicular phase and decrease after GnRH-analog administration in women with endometriosis and chronic pelvic pain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Purpose Endometriosis is the leading single cause of chronic pelvic pain (CPP). To date, the gold standard to diagnose this condition is histologic confirmation of lesions obtained by surgery. However, a noninvasive and cheaper tool for early diagnosis is strongly needed. The aim of this study is twofold: first, to assess the diagnostic accuracy to detect endometriosis of serum CA 125 modifications throughout the menstrual cycle, and second, to analyze whether variations in CA 125 levels following one dose of GnRH-analog (GnRH-a) may increase the diagnostic value of the assay. Methods 84 women scheduled for a diagnostic laparoscopy for CPP (group A) and another 12 women scheduled for diagnostic laparoscopy for unexplained infertility (group B) were enrolled as cases and controls. Serum CA125 was determined for each patient at the early follicular and luteal phases. Prior to surgery, patients from group A received one vial of leuprolide acetate depot. Following laparoscopy and histologic examination, cases were sub-grouped into group A1 (subjects with endometriosis) and group A2 (subjects without endometriosis). Results Plasma CA125 levels during the early follicular phase were significantly higher than those recorded in the luteal phase in all groups and they were significantly higher in group A1 in comparison with groups A2 and B. One month after GnRH administration, a significant reduction in plasma CA-125 levels was only observed in group A1. Conclusions The assessment of serum CA 125 modifications throughout the menstrual cycle and following one dose of GnRH-a demonstrated good diagnostic accuracy to detect endometriosis in patients with CPP. Women with endometriosis are characterized by a significant increase in CA125 levels during the early follicular phase and by a significant decrease following GnRH-a administration.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_paininfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (31)

Cited by (4)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK